Southeast Asia
regional insights.

PharmaLinea’s Business Development team has recently concluded an extensive business trip in Southeast Asia, visiting partners and new contacts. Mr. Jernej Klopčič, our Business Development Director, was asked to share some of his experience in an interview by NutraIngredients-Asia, scheduled to be published shortly. He also conveyed some of the latest insights from the region for us.

growth & quality.

Klopčič stated: “We’ve been seeing a lot of demand and consequently concentrated a lot of our activities in Southeast Asia in the past couple of years and it’s no coincidence. It all stems from a growing middle to upper-class consumer base, that is not only health-conscious but also educated. We find our best partners in markets where consumers value scientific support and this is increasingly becoming the characteristic of Southeast Asia.”

The number of pharmaceutical companies in the region starting nutraceutical subdivisions speaks of how the market is evolving towards quality.

Such companies demand product stability and fit our high-quality standards. Additionally, there has been a trend lately of more and more Southeast Asian countries demanding GMP certification of food supplement manufacturers. This clearly reflects the quality direction the region is headed towards.

The highest growth for the next 5 years is expected for Thailand and Vietnam, while the more mature market of South Korea is projected to exhibit less growth. However, the latter is already nearly 4 times the size of the UK market.


{Your} Iron Syrup’s efficiency was confirmed in a gold-standard clinical trial encompassing 50 children. Upon administration of our product for 12 months, ferritin levels were icreased by 56% when compared to placebo.

indications, forms & plans.

Klopčič went on to add: “The top-performing categories vary significantly from market to market, but the most common to take top positions are immune system, bone health, cognitive health, beauty and other health areas. The latter is a category where we often find products such as the ones addressing iron deficiency, where we are specialists. Our iron line has been in high demand because iron deficiency is typically more problematic in the region and the available solutions often come with drawbacks such as low absorption and side effects.

With markets evolving faster and faster and consumers in Southeast Asia demanding more and more from their supplement user experience, we are increasingly partnering with companies in the region by providing them with supplements in liquids, sachets, sprays, and other user-friendly product forms. Not to dismiss more traditional, yet still successful capsules and tablets.

We are currently working in Vietnam and South Korea and we are in various stages of registration processes in Indonesia, Malaysia, and the Philippines. We have already seen 100% growth in business from Southeast Asia last year and we project the growth to rise to more than 150% with the launch of more products.”

This year we are expecting results of two clinical trials –
on our immunity and iron supplements.

The trials were designed according to gold standards and with them, we plan to fill the gaps in the two segments by providing our clients with clearly differentiated products and clinically proven efficacy. We are also successfully developing business in the region with solutions addressing sleep and prenatal supplementation.

In our view, the only way to get lasting consumer trust is to provide supplements with benefits one can feel and prove.

reach out.

PharmaLinea © 2024